Concepedia
Statistics
Publications
23
Citations
1.4K
H-Index
20
Active since
1990
Affiliations
Pfizer (United States)(Current)
Gaertner (United States)
University of Michigan
Sunesis (United States)
Northwestern University
Mark G. Vartanian is an author at Pfizer (United States) specializing in pharmacology, neuropharmacology, and medicine.
Publications per year
1990–2015
Structure−Activity Relationships of Pregabalin and Analogues That Target the α<sub>2</sub>-δ Protein
Thomas R. Belliotti, Thomas Capiris, I. Victor Ekhato et al. · Journal of Medicinal Chemistry · 2005 · 210 citations
Medicine, Medicinal Chemistry, Pharmacology +17
Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin
Charles P. Taylor, Mark G. Vartanian, Po‐wai Yuen et al. · Epilepsy Research · 1993 · 149 citations
Medicine, Neuroscience, Pharmacology +11
Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate
Devin Welty, Gerald P. Schielke, Mark G. Vartanian et al. · Epilepsy Research · 1993 · 122 citations
Medicine, Pharmacokinetics, Pharmacology +10
Substituted 2-Benzothiazolamines as Sodium Flux Inhibitors: Quantitative Structure-Activity Relationships and Anticonvulsant Activity
Sheryl J. Hays, Michael J. Rice, Daniel F. Ortwine et al. · Journal of Pharmaceutical Sciences · 1994 · 108 citations
Pharmacy, Medicinal Chemistry, Pharmacology +8
3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents
Charles P. Taylor, Mark G. Vartanian, Ryszard Andruszkiewicz et al. · Epilepsy Research · 1992 · 96 citations
Medicine, Medicinal Chemistry, Pharmacology +13
1–5 of 23